These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25840798)

  • 1. Design of a selenylsulfide-bridged EGFR dimerization arm mimic.
    Hanold LE; Watkins CP; Ton NT; Liaw P; Beedle AM; Kennedy EJ
    Bioorg Med Chem; 2015 Jun; 23(12):2761-6. PubMed ID: 25840798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics.
    Hanold LE; Oruganty K; Ton NT; Beedle AM; Kannan N; Kennedy EJ
    PLoS One; 2015; 10(3):e0118796. PubMed ID: 25790232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting Epidermal Growth Factor Receptor Dimerization and Signaling Through Targeted Delivery of a Juxtamembrane Domain Peptide Mimic.
    Gerhart J; Thévenin AF; Bloch E; King KE; Thévenin D
    ACS Chem Biol; 2018 Sep; 13(9):2623-2632. PubMed ID: 30133245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.
    Fulton MD; Hanold LE; Ruan Z; Patel S; Beedle AM; Kannan N; Kennedy EJ
    Bioorg Med Chem; 2018 Mar; 26(6):1167-1173. PubMed ID: 28911855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of a Proapoptotic Peptide to EGFR-Positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR.
    Toyama K; Nomura W; Kobayakawa T; Tamamura H
    Bioconjug Chem; 2018 Jun; 29(6):2050-2057. PubMed ID: 29763296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting a controversy: The effect of EGF on EGFR dimer stability.
    Singh DR; King C; Salotto M; Hristova K
    Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183015. PubMed ID: 31295474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor.
    Mizuguchi T; Ohara N; Iida M; Ninomiya R; Wada S; Kiso Y; Saito K; Akaji K
    Bioorg Med Chem; 2012 Oct; 20(19):5730-7. PubMed ID: 22959765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.
    Naik H; Gauthier T; Singh S; Jois S
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3506-3513. PubMed ID: 30314880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
    Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
    Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β(3R3)-Peptides: design and synthesis of novel peptidomimetics and their self-assembling properties at the air-water interface.
    Mosca S; Dannehl C; Möginger U; Brezesinski G; Hartmann L
    Org Biomol Chem; 2013 Sep; 11(33):5399-403. PubMed ID: 23860843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.
    Gentilucci L; De Marco R; Cerisoli L
    Curr Pharm Des; 2010; 16(28):3185-203. PubMed ID: 20687878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR).
    Zhu H; Zhao L; Li Z; Wen B; Qiu C; Liu M; Xu Z; Hu S; Li H
    Protein Expr Purif; 2019 May; 157():57-62. PubMed ID: 30735705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review.
    Fischer PM
    Curr Protein Pept Sci; 2003 Oct; 4(5):339-56. PubMed ID: 14529528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.
    Jia Y; Yun CH; Park E; Ercan D; Manuia M; Juarez J; Xu C; Rhee K; Chen T; Zhang H; Palakurthi S; Jang J; Lelais G; DiDonato M; Bursulaya B; Michellys PY; Epple R; Marsilje TH; McNeill M; Lu W; Harris J; Bender S; Wong KK; Jänne PA; Eck MJ
    Nature; 2016 Jun; 534(7605):129-32. PubMed ID: 27251290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: a rational approach for inhibiting dimerization of G protein-coupled receptors.
    Hurevich M; Ratner-Hurevich M; Tal-Gan Y; Shalev DE; Ben-Sasson SZ; Gilon C
    Bioorg Med Chem; 2013 Jul; 21(13):3958-66. PubMed ID: 23706536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.
    Westerfield JM; Barrera FN
    J Biol Chem; 2020 Feb; 295(7):1792-1814. PubMed ID: 31879273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a (3R,6S,9S)-2-oxo-1-azabicyclo[4.3.0]nonane scaffold as a mimic of Xaa-trans-Pro in poly-L-proline type II helix conformation.
    Aillard B; Kilburn JD; Blaydes JP; Tizzard GJ; Findlow S; Werner JM; Bloodworth S
    Org Biomol Chem; 2015 Apr; 13(15):4562-9. PubMed ID: 25777583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.
    Harjani JR; Yap BK; Leung EW; Lucke A; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Norton RS; Baell JB
    J Med Chem; 2016 Jun; 59(12):5799-809. PubMed ID: 27214043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.